| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 79.63B | 81.31B | 80.49B | 80.47B | 80.85B | 86.79B |
| Gross Profit | 26.19B | 25.90B | 26.69B | 25.91B | 25.73B | 31.18B |
| EBITDA | 6.61B | 5.67B | 6.64B | 6.58B | 7.32B | 13.91B |
| Net Income | 3.73B | 7.32B | 4.15B | 5.45B | 5.86B | 7.79B |
Balance Sheet | ||||||
| Total Assets | 159.62B | 177.48B | 157.76B | 164.82B | 155.94B | 155.46B |
| Cash, Cash Equivalents and Short-Term Investments | 20.69B | 20.35B | 21.06B | 16.42B | 9.56B | 22.69B |
| Total Debt | 5.81B | 6.14B | 7.54B | 7.57B | 4.29B | 4.56B |
| Total Liabilities | 37.05B | 40.55B | 33.40B | 35.39B | 35.35B | 36.87B |
| Stockholders Equity | 122.57B | 136.93B | 124.36B | 129.42B | 120.58B | 118.58B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 673.00M | 7.50B | 4.59B | -9.74B | 5.16B |
| Operating Cash Flow | 0.00 | 5.57B | 11.54B | 7.91B | -7.59B | 8.43B |
| Investing Cash Flow | 0.00 | 1.69B | -2.14B | -1.06B | 853.00M | -2.39B |
| Financing Cash Flow | 0.00 | -8.58B | -4.71B | -533.00M | -6.35B | -2.90B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥106.27B | 14.52 | ― | 4.76% | 1.01% | 79.22% | |
78 Outperform | ¥112.32B | 11.92 | 22.46% | 4.06% | -4.92% | 94.42% | |
65 Neutral | ¥214.52B | 13.92 | ― | 2.70% | 8.28% | 7.21% | |
63 Neutral | ¥921.63B | 51.53 | 6.07% | 3.69% | 3.69% | -66.27% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
61 Neutral | ¥4.08T | 12.01 | ― | 3.27% | 1.75% | 93.78% |